Effects of serum bilirubin on atherosclerotic processes

References

• Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem. 2007; 43:1–57.
   PubMed Web of Science ®Google Scholar
• Vitek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des. 2009;15:2869–83.
   PubMed Web of Science ®Google Scholar
• Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, et al. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res. 2005;49:1030–43.
   PubMed Web of Science ®Google Scholar
• Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med. 2008;45:562–9.
   PubMed Web of Science ®Google Scholar
• Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med. 1995;333:1171–5.
   PubMed Web of Science ®Google Scholar
• Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517–54.
   PubMed Web of Science ®Google Scholar
• Nath KA. The functional significance of induction of heme oxygenase by oxidant stress. J Lab Clin Med. 1994;123:461–3.
   PubMed Web of Science ®Google Scholar
• Pimstone NR, Tenhunen R, Seitz PT, Marver HS, Schmid R. The enzymatic degradation of hemoglobin to bile pigments by macrophages. J Exp Med. 1971;133:1264–81.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86: 583–650.
   PubMed Web of Science ®Google Scholar
• Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–6.
   PubMed Web of Science ®Google Scholar
• Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A. 2002; 99:16093–8.
   PubMed Web of Science ®Google Scholar
• Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002;160:449–56.
   PubMed Web of Science ®Google Scholar
• Vitek L, Kraslova I, Muchova L, Novotny L, Yamaguchi T. Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome. J Gastroenterol Hepatol. 2007;22:841–5.
   PubMed Web of Science ®Google Scholar
• Mazzone GL, Rigato I, Ostrow JD, Bossi F, Bortoluzzi A, Sukowati CH, et al. Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun. 2009;386:338–44.
   PubMed Web of Science ®Google Scholar
• Tapan S, Dogru T, Tasci I, Ercin CN, Ozgurtas T, Erbil MK. Soluble CD40 ligand and soluble P-selectin levels in Gilbert’s syndrome: a link to protection against atherosclerosis?Clin Biochem. 2009; 42:791–5.
   PubMed Web of Science ®Google Scholar
• Basiglio CL, Arriaga SM, Pelusa HF, Almara AM, Roma MG, Mottino AD. Protective role of unconjugated bilirubin on complement-mediated hepatocytolysis. Biochim Biophys Acta. 2007;1770:1003–10.
   PubMed Web of Science ®Google Scholar
• Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med. 2011;49:1823–8.
   PubMed Web of Science ®Google Scholar
• Yoshino S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Oketani N, et al. Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients. J Atheroscler Thromb. 2011;18:403–12.
   PubMed Web of Science ®Google Scholar
• Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994;40:18–23.
   PubMed Web of Science ®Google Scholar
• Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1996; 16:250–5.
   PubMed Web of Science ®Google Scholar
• Schwertner HA. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis. 1998;136:383–7.
   PubMed Web of Science ®Google Scholar
• Schwertner HA, Fischer JR, Jr. Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. Atherosclerosis. 2000;150:381–7.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Fukui M, Tomiyasu K, Akabame S, Nakano K, Hasegawa G, et al. Low serum bilirubin concentration is associated with coronary artery calcification (CAC). Atherosclerosis. 2009;206:287–91.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Kim D, Park HE, Chung GE, Choi SH, Choi SY, et al. Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis. Atherosclerosis. 2013;230:242–8.
   PubMed Web of Science ®Google Scholar
• Gullu H, Erdogan D, Tok D, Topcu S, Caliskan M, Ulus T, et al. High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol. 2005;25:2289–94.
   PubMed Web of Science ®Google Scholar
• Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198:1–11.
   PubMed Web of Science ®Google Scholar
• Djousse L, Levy D, Cupples LA, Evans JC, D’Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol. 2001;87:1196–200; A1194, 1197.
   PubMed Web of Science ®Google Scholar
• Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 2003;228:568–71.
   PubMed Web of Science ®Google Scholar
• Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke. 2009;40:3422–7.
   PubMed Web of Science ®Google Scholar
• Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999–2004. Am J Med. 2008;121:781–8e781.
   PubMed Web of Science ®Google Scholar
• Vitek L, Novotny L, Sperl M, Holaj R, Spacil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis. 2006;21:408–14.
   PubMed Web of Science ®Google Scholar
• Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006; 184:431–7.
   PubMed Web of Science ®Google Scholar
• Dullaart RPF, Kappelle PJWH, de Vries R. Lower carotid intima media thickness is predicted by higher serum bilirubin in noth non-diabetic and Type 2 diabetic subjects. Clin Chim Acta. 2012;414:161–5.
   PubMed Web of Science ®Google Scholar
• Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to2004. Arterioscler Thromb Vasc Biol.2008;28:166–72.
   Google Scholar
• Lin LY, Kuo HK, Hwang JJ, Lai LP, Chiang FT, Tseng CD, et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis. 2009; 203:563–8.
   PubMed Web of Science ®Google Scholar
• Cheriyath P, Gorrepati VS, Peters I, Nookala V, Murphy ME, Srouji N, et al. High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999–2006. J Clin Med Res.2010; 2:201–6.
   Google Scholar
• Huang SS, Huang PH, Leu HB, Wu TC, Lin SJ, Chen JW. Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X. Heart. 2010;96:1227–32.
   PubMed Web of Science ®Google Scholar
• Ong KL, Wu BJ, Cheung BM, Barter PJ, Rye KA. Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999–2008. Atherosclerosis.2011;219:728–33.
   Google Scholar
• Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–478.
   PubMed Web of Science ®Google Scholar
• Stocker R, Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases?Circulation. 2006;114:2178–89.
   PubMed Web of Science ®Google Scholar
• Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal. 2004;6:841–9.
   PubMed Web of Science ®Google Scholar
• Clark JE, Foresti R, Green CJ, Motterlini R. Dynamics of heme oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J. 2000;348(Pt 3):615–19.
   PubMedGoogle Scholar
• Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci. 1994;54:P477–81.
   PubMed Web of Science ®Google Scholar
• Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A. 2009;106:5171–6.
   PubMed Web of Science ®Google Scholar
• Dennery PA, McDonagh AF, Spitz DR, Rodgers PA, Stevenson DK. Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn rats exposed to hyperoxia. Free Radic Biol Med. 1995;19: 395–404.
   PubMed Web of Science ®Google Scholar
• Benitez S, Sanchez-Quesada JL, Lucero L, Arcelus R, Ribas V, Jorba O, et al. Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. Atherosclerosis. 2002;160: 223–32.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest. 1997;100:1209–16.
   PubMed Web of Science ®Google Scholar
• Morita T, Imai T, Yamaguchi T, Sugiyama T, Katayama S, Yoshino G. Induction of heme oxygenase-1 in monocytes suppresses angiotensin II-elicited chemotactic activity through inhibition of CCR2: role of bilirubin and carbon monoxide generated by the enzyme. Antioxid Redox Signal. 2003;5:439–47.
   PubMed Web of Science ®Google Scholar
• Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol. 2005;174:3709–18.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Takahashi K, Komaru T, Fukuchi M, Shioiri H, Sato K, et al. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001;21:1373–7.
   PubMed Web of Science ®Google Scholar
• Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res. 1999;85:663–71.
   PubMed Web of Science ®Google Scholar
• Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol. 2005;25:155–60.
   PubMed Web of Science ®Google Scholar
• Mazzone GL, Rigato I, Ostrow JD, Tiribelli C. Bilirubin effect on endothelial adhesion molecules expression is mediated by the NF-kappaB signaling pathway. Biosci Trends. 2009;3:151–7.
   PubMed Web of Science ®Google Scholar
• Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation. 2005;112:1030–9.
   PubMed Web of Science ®Google Scholar
• Ollinger R, Yamashita K, Bilban M, Erat A, Kogler P, Thomas M, et al. Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle. 2007;6:39–43.
   PubMed Web of Science ®Google Scholar
• Peyton KJ, Shebib AR, Azam MA, Liu XM, Tulis DA, Durante W. Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration. Front Pharmacol. 2012;3:48.
   PubMed Web of Science ®Google Scholar
• Stoeckius M, Erat A, Fujikawa T, Hiromura M, Koulova A, Otterbein L, et al. Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2 + influx in growth arrest of human vascular smooth muscle cells by bilirubin. J Biol Chem. 2012;287:15418–26.
   PubMed Web of Science ®Google Scholar
• Kuwano T, Miura S, Shirai K, Ike A, Mori K, Shimizu T, et al. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb. 2011;18:574–83.
   PubMed Web of Science ®Google Scholar
• Rodella L, Lamon BD, Rezzani R, Sangras B, Goodman AI, Falck JR, et al. Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic Biol Med. 2006;40:2198–205.
   PubMed Web of Science ®Google Scholar
• Wei Y, Liu XM, Peyton KJ, Wang H, Johnson FK, Johnson RA, et al. Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol. 2009;297:C907–15.
   Web of Science ®Google Scholar
• Kumar V, Butcher SJ, Oorni K, Engelhardt P, Heikkonen J, Kaski K, et al. Three-dimensional cryoEM reconstruction of native LDL particles to 16A resolution at physiological body temperature. PLoS One. 2011;6:e18841.
   PubMed Web of Science ®Google Scholar
• Levinson SS. Relationship between bilirubin, apolipoprotein B, and coronary artery disease. Ann Clin Lab Sci. 1997;27:185–92.
   PubMed Web of Science ®Google Scholar
• O’Kane MJ, Lynch PL, Callender ME, Trimble ER. Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis. Atherosclerosis. 1997;131:203–10.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ahsan MH, Purchio AF, West DB. Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. J Immunol. 2005;174:8125–34.
   PubMed Web of Science ®Google Scholar
• Dullaart RP, de Boer JF, Annema W, Tietge UJ. The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects. Obesity (Silver Spring). 2013;21: 361–6.
   PubMed Web of Science ®Google Scholar
• Deetman PE, Bakker SJ, Dullaart RP. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc Diabetol. 2013;12:166.
   PubMed Web of Science ®Google Scholar
• McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis. 2001;154: 229–36.
   PubMed Web of Science ®Google Scholar
• Abraham NG, Kappas A. Heme oxygenase and the cardiovascular- renal system. Free Radic Biol Med. 2005;39:1–25.
   PubMed Web of Science ®Google Scholar
• Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 2003;17:1759–61.
   PubMed Web of Science ®Google Scholar
• Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med. 2001;7:693–8.
   PubMed Web of Science ®Google Scholar
• Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001; 89:168–73.
   PubMed Web of Science ®Google Scholar
• Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A. 1997;94:10919–24.
   PubMed Web of Science ®Google Scholar
• Benallaoua M, Francois M, Batteux F, Thelier N, Shyy JY, Fitting C, et al. Pharmacologic induction of heme oxygenase 1 reduces acute inflammatory arthritis in mice. Arthritis Rheum. 2007;56: 2585–94.
   PubMedGoogle Scholar
• Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422–8.
   PubMed Web of Science ®Google Scholar
• Stender S, Frikke-Schmidt R, Nordestgaard BG, Grande P, Tybjaerg-Hansen A. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis. J Intern Med. 2013;273:59–68.
   PubMed Web of Science ®Google Scholar
• Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol. 2003;38:107–17.
   PubMed Web of Science ®Google Scholar
• Bosma PJ, van der Meer IM, Bakker CT, Hofman A, Paul-Abrahamse M, Witteman JC. UGT1A1*28 allele and coronary heart disease: the Rotterdam Study. Clin Chem. 2003;49:1180–1.
   PubMed Web of Science ®Google Scholar
• Schwertner HA. Bilirubin concentration, UGT1A1*28 polymorphism, and coronary artery disease. Clin Chem. 2003;49:1039–40.
   PubMed Web of Science ®Google Scholar
• Gajdos V, Petit FM, Perret C, Mollet-Boudjemline A, Colin P, Capel L, et al. Further evidence that the UGT1A1*28 allele is not associated with coronary heart disease: The ECTIM Study. Clin Chem. 2006;52:2313–14.
   PubMed Web of Science ®Google Scholar
• Lin JP, O’Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006;114:1476–81.
   PubMed Web of Science ®Google Scholar
• Tuzun F, Kumral A, Duman N, Ozkan H. Breast milk jaundice: effect of bacteria present in breast milk and infant feces. J Pediatr Gastroenterol Nutr. 2013;56:328–32.
   PubMed Web of Science ®Google Scholar
• Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, et al. High-fat diet alters gut microbiota physiology in mice. ISME J. 2014;8:295–308.
   PubMed Web of Science ®Google Scholar